Study demonstrates utility of Entegrion VCM System for anticoagulation monitoring of Covid-19 patients
The VCM test result was used as a daily assessment of the effect of heparin on the viscoelastic properties of 36 critically ill COVID-19 patients. The VCM results were retrospectively compared with laboratory parameters. Anticoagulation was provided with either UFH (52 samples) or with LMWH (low molecular weight heparin) (86 samples). UFH influenced all VCM parameters toward hypocoagulability; LMWH did not. The effect of UFH was better correlated with VCM clotting time (CT) than with aPTT.
See here for the full publication : Viscoelastic Coagulation Monitor (VCM) as a novel device to… : ASAIO Journal (lww.com)